Skip to content
Not yet recruitingPhase 2

Exploring Ketamine's Effects on Depression and Anxiety in Adults With Low Vision

NCT07934043 · Stanford University

Closed to entry
Status
Not accepting participants
Phase 2
Phase
40
Target enrolment
1
Study sites
1 US states

What it is testing

Summary

The purpose of this open-label study is to evaluate the effects of a single intravenous infusion of ketamine on depression and anxiety in adults with low vision.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Change in depression symptom severity as measured by the Hamilton Depression Rating Scale 17 (HDRS-17)

    Measured over Baseline (pre-infusion) to 1 week (post-infusion)

  • Change in anxiety symptom severity as measured by the Hamilton Anxiety Rating Scale (HAM-A)

    Measured over Baseline (pre-infusion) to 1 week (post-infusion)

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years
Ages
All
Sex
Accepted
Healthy volunteers
Inclusion Criteria for Participants with Low Vision: * Ages 18 and older * Qualifies as a low vision participant based on ophthalmology assessments * Capacity to provide informed consent Inclusion Criteria for Healthy Controls: * Ages 18 and older * Qualifies as a normal vision participant based on ophthalmology assessments * Capacity to provide informed consent * Likely able to tolerate clinical study procedures * No current or lifetime psychiatric diagnosis * No current or past use of psychotropic medication Exclusion Criteria for Participants with Low Vision and Healthy Controls: * allergy to ketamine * Any current or past medical/psychiatric condition that makes participation unsafe in the opinion of the investigator or study physician * Pregnant or nursing, or able to become pregnant and are not practicing an effective means of birth control

Where

1 study site

FacilityCityRegionCountry
Department of Psychiatry & Behavioral SciencesStanfordCaliforniaUnited States

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record. The registry also holds the most current version of everything above.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT07934043 on ClinicalTrials.gov →

Last updated in the registry 2026-11-12. Registry records change; this page reflects the data build of 2026-11-17.

Related

Where this trial sits